Global Safety Database Summary of COVID-19-Related Drug Utilization-Safety Surveillance: A Sponsor’s Perspective

INTRODUCTION: Evidence-based clinical data on coronavirus disease 2019 (COVID-19) pharmacotherapies are scarce. OBJECTIVE: This study documented and characterized COVID-19 cases reported in individuals receiving treatment with Pfizer pharmaceutical products and cases that reported use of Pfizer phar...

Descripción completa

Detalles Bibliográficos
Autores principales: Beyzarov, Elena, Chen, Yan, Julg, Rob, Naim, Karen, Shah, Jigna, Gregory, William W., Ayoub, Ayman, Caubel, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755229/
https://www.ncbi.nlm.nih.gov/pubmed/33354753
http://dx.doi.org/10.1007/s40264-020-01035-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755229/
https://www.ncbi.nlm.nih.gov/pubmed/33354753
http://dx.doi.org/10.1007/s40264-020-01035-x

Ejemplares similares